Press Releases

GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection[...]

SYMPLIFY Results Demonstrate Strong Performance of GRAIL’s Multi-Cancer Early Detection Methylation-Based Platform in Individuals Presenting With Non-Specific Signs and Symptoms Results In Press For Publication in The Lancet Oncology MENLO PARK, Calif. and OXFORD, United Kingdom, June 1, 2023 — GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be […]

View Full Release
Img
GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting
View Full Release
06/03/2023
Img
New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing
View Full Release
06/03/2023
Img
GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting
View Full Release
06/01/2023
Img
Grail to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting
View Full Release
05/22/2023
Img
GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023
View Full Release
04/19/2023
Img
FirstHealth of the Carolinas to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection Blood Test
View Full Release
04/18/2023
Img
GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research Annual Meeting 2023
View Full Release
04/17/2023
Img
GRAIL Showcases Methylation Platform Performance Across Cancer Continuum with New Data at American Association for Cancer Research (AACR) Annual Meeting
View Full Release
04/11/2023
Img
Providence and GRAIL Expand Partnership to Increase Access to Galleri® Multi-Cancer Early Detection Screening
View Full Release
04/04/2023
Img
John Hancock expands access to Galleri®, GRAIL’s breakthrough cancer screening technology
View Full Release
02/23/2023
Img
GRAIL Teams Up with Professional Golfers David Duval and Juli Inkster to Raise Awareness of Multi-Cancer Early Detection
View Full Release
02/22/2023
Img
GRAIL Introduces State-of-the-Art Methylation-Based Solution to Accelerate Cancer Research in the Post-Diagnosis Setting
View Full Release
01/09/2023
Img
The Galleri Classic Announces Six Coachella Valley-Based Charitable Partners in its Mission to Combat Cancer
View Full Release
12/21/2022
Img
Point32Health and GRAIL Expand Galleri® Multi-Cancer Early Detection Blood Test Pilot to Harvard Pilgrim Health Care Members on the Maine Health Insurance Marketplace
View Full Release
12/15/2022
Img
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
View Full Release
11/17/2022
Img
GRAIL and Carrum Health Partner to Include Galleri® as Part of Comprehensive Cancer Care Offering to Employers
View Full Release
10/13/2022
Img
Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test
View Full Release
09/22/2022
Img
John Hancock Becomes First Life Insurance Carrier to Offer Access to GRAIL’s Multi-Cancer Early Detection Test to Customers
View Full Release
09/20/2022
Img
GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022
View Full Release
09/11/2022
Img
GRAIL to Present Final Multi-Cancer Early Detection Data from the Interventional PATHFINDER Study at ESMO Congress 2022
View Full Release
09/08/2022
Img
GRAIL and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test
View Full Release
07/18/2022
Img
Mercy Offers New GRAIL Blood Test to Detect 50+ Types of Cancer
View Full Release
07/12/2022
Img
Community Health Network and GRAIL Partner to Offer Galleri® Multi-Cancer Early Detection Test in Central Indiana
View Full Release
06/28/2022
Img
GRAIL and Fountain Health Insurance Partner to Provide Coverage of Galleri® Multi-Cancer Early Detection Test
View Full Release
06/21/2022
Img
GRAIL and England’s National Health Service (NHS) Present Trial Design for Largest Study of Multi-Cancer Early Detection Test at ASCO Annual Meeting
View Full Release
06/06/2022
Img
GRAIL and Ochsner Health Launch New Initiatives to Improve Cancer Detection Rates in Louisiana
View Full Release
06/03/2022
Img
GRAIL Announces Strategic Collaboration with AstraZeneca to Develop Companion Diagnostic Tests to Enable the Treatment of Early-Stage Cancer
View Full Release
06/02/2022
Img
GRAIL Announces Collaboration with U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test
View Full Release
05/31/2022
Img
GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri® Multi-Cancer Early Detection Blood Test to Eligible Patients in Utah
View Full Release
05/17/2022
Img
PGA TOUR Champions and GRAIL Announce The Galleri® Classic
View Full Release
04/19/2022
Img
GRAIL and Point32Health Collaborate to Offer Galleri® Multi-Cancer Early Detection Blood Test
View Full Release
02/15/2022
Img
GRAIL Statement on President Biden’s Bold Initiative to Reignite the Cancer Moonshot
View Full Release
02/02/2022
Img
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test
View Full Release
01/10/2022
Img
GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
View Full Release
01/10/2022
Img
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test
View Full Release
12/06/2021
Img
GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test
View Full Release
09/20/2021
Img
NHS Launches UK Trial of the Galleri Multi-Cancer Early Detection Blood Test
View Full Release
09/12/2021
Img
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
View Full Release
08/18/2021
Img
GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test
View Full Release
06/04/2021
Img
Statement on the Passing of Dr. José Baselga, from his friends at GRAIL
View Full Release
03/21/2021
Img
GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
View Full Release
03/16/2021
Img
GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test
View Full Release
03/02/2021
Img
Multi-Cancer Early Detection Company GRAIL Now Hiring For State-Of-The-Art Laboratory Facility in Research Triangle Park
View Full Release
02/25/2021
Img
GRAIL and Quest Diagnostics Announce Collaboration to Support Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test  
View Full Release
02/23/2021
Img
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease
View Full Release
01/11/2021
Img
GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
View Full Release
01/11/2021
Img
New Research Suggests Multi-Cancer Early Detection Blood Test Could Reduce Late-Stage Cancer Diagnoses by More Than Half
View Full Release
12/16/2020
Img
GRAIL and UK Government to Make Galleri Multi-Cancer Early Detection Blood Test Available to Patients
View Full Release
11/26/2020
Img
Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
View Full Release
09/21/2020
Img
GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering
View Full Release
09/09/2020
Img
Cleveland Clinic Joins Interventional Study Using GRAIL's Multi-Cancer Early Detection Test to Help Guide Clinical Care
View Full Release
08/06/2020
Img
GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II
View Full Release
06/22/2020
Img
GRAIL Stands Against Injustice and Racism
View Full Release
06/06/2020
Img
NC Gov. Cooper: Governor Cooper Announces Nearly 400 New Jobs in Durham as Multi-Cancer Early Detection Company Chooses New Laboratory Location
View Full Release
06/02/2020
Img
GRAIL to Participate in BofA Securities 2020 Health Care Conference
View Full Release
05/07/2020
Img
GRAIL Announces $390 Million Series D Financing
View Full Release
05/06/2020
Img
Mostafa Ronaghi Joins GRAIL’s Board of Directors
View Full Release
05/04/2020
Img
GRAIL Appoints Satnam Alag as Senior Vice President of Software Engineering
View Full Release
04/29/2020
Img
GRAIL to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting
View Full Release
04/26/2020
Img
GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe
View Full Release
04/10/2020
Img
GRAIL Announces Validation of its Multi-Cancer Early Detection Test Published in Annals of Oncology
View Full Release
03/30/2020
Img
GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care
View Full Release
02/18/2020
Img
GRAIL Appoints Gautam Kollu as Chief Commercial Officer
View Full Release
12/16/2019
Img
GRAIL Appoints Matthew Young as Chief Operating Officer and Chief Financial Officer
View Full Release
10/07/2019
Img
GRAIL Announces Positive Validation Data for its Multi-Cancer Early Detection Test
View Full Release
10/07/2019
Img
GRAIL Appoints Marissa Song as General Counsel and Corporate Secretary
View Full Release
09/30/2019
Img
GRAIL to Present New Data in Late-Breaking Oral Presentation at the European Society for Medical Oncology (ESMO) 2019 Congress
View Full Release
09/27/2019
Img
GRAIL Appoints Rodger Currie as Head of Government Affairs and Alliance Development
View Full Release
08/26/2019
Img
GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments
View Full Release
06/06/2019
Img
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study
View Full Release
05/31/2019
Img
GRAIL Announces Promising New Data with Early Detection Blood Test to be Presented at 2019 American Society of Clinical Oncology Annual Meeting
View Full Release
05/15/2019
Img
GRAIL Announces Significant Progress with Multi-Cancer Early Detection Test Including FDA Breakthrough Device Designation
View Full Release
05/13/2019
Img
GRAIL Announces Appointment of Catherine Friedman as Chair of GRAIL Board
View Full Release
12/10/2018
Img
GRAIL Announces Plans to Initiate SUMMIT Study to Support Development of Blood Test for Early Cancer Detection
View Full Release
12/03/2018
Img
GRAIL to Present New Data from the Circulating Cell-free Genome Atlas (CCGA) Study at the European Society for Medical Oncology (ESMO) 2018 Congress
View Full Release
10/19/2018
Img
GRAIL Announces Appointment of Renée Galá as Chief Financial Officer
View Full Release
10/04/2018
Img
GRAIL Announces Appointment of Hal Barron and Hans Bishop to its Board of Directors
View Full Release
08/09/2018
Img
GRAIL Announces Appointment of Key Executives as Company Makes Continued Progress in Development of Early Detection Products
View Full Release
07/09/2018
Img
GRAIL Announces Data on Detection of Early-Stage Lung Cancers
View Full Release
06/02/2018
Img
GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing
View Full Release
05/21/2018
Img
GRAIL to Present New Data from Circulating Cell-free Genome Atlas (CCGA) Study at 2018 American Society of Clinical Oncology Annual Meeting
View Full Release
05/16/2018
Img
GRAIL Announces Data from Prototype Blood Tests for Early Cancer Detection
View Full Release
04/17/2018
Img
GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer
View Full Release
12/14/2017
Img
GRAIL Appoints Chairman Bill Rastetter to Chief Executive Officer
View Full Release
08/02/2017
Img
GRAIL Announces Data From Early Research Analyzing its High-Intensity Sequencing Approach
View Full Release
06/03/2017
Img
GRAIL Announces Board of Directors Appointments
View Full Release
05/04/2017
Img
GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early
View Full Release
04/20/2017
Img
GRAIL and Cirina Combine to Create Global Company Focused on Early Detection of Cancer
View Full Release
03/31/2017
Img
GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early
View Full Release
03/01/2017
Img
GRAIL Plans to Raise in Excess of $1B in Series B Funding
View Full Release
01/05/2017
Img
GRAIL Announces Circulating Cell-free Genome Atlas (CCGA) Study as Foundation for Development of Blood Test to Detect Cancer Early
View Full Release
12/01/2016
Img
GRAIL Hires Google Executive Jeff Huber as CEO to Lead Development for Early Cancer Detection
View Full Release
02/10/2016
Img
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
View Full Release
01/10/2016

Contact us

1525 O'Brien Drive Menlo Park, CA 94025 | (833)-694-2553

Get in touch